Skip to main content
. 2023 Jun 29;13:1199043. doi: 10.3389/fonc.2023.1199043

Table 3.

Multivariable analyses of RILI – associated factors (Logistic Regression).

Variables n/N OR 95% CI P values AIC BIC
Baseline respiratory disease
Chemotherapy
Nodal RT
Dmean
11/205
29/839
23/561
3.041.67
1.96
1.06
[1.46, 6.31]
[0.70, 4.01]
[0.89, 4.34]
[0.99, 1.13]
<0.01
0.25
0.10
0.08
335 361
Baseline respiratory disease
Chemotherapy
Nodal RT
V 5 Gy
11/205
29/839
23/561
2.97
1.80
1.70
1.01
[1.43,6.16]
[0.75, 4.31]v[0.52, 5.54]
[0.99, 1.03]
<0.01
0.19
0.38
0.49
337 364
Baseline respiratory disease
Chemotherapy
Nodal RT
V 10 Gy
11/205
29/839
23/561
2.95
1.84
2.20
1.01
[1.42,6.13]
[0.77, 4.41]
[0.72, 6.75]
[0.98, 1.03]
<0.01
0.17
0.17
0.90
338 364
Baseline respiratory disease
Chemotherapy
Nodal RT
V 15 Gy
11/205
29/839
23/561
3.00
1.81
1.78
1.01
[1.45,6.24]
[0.76, 4.33]
[0.57, 5.58]
[0.97, 1.05]
<0.01
0.18
0.32
0.53
337 364
Baseline respiratory disease
Chemotherapy
Nodal RT
V 20 Gy
11/205
29/839
23/561
3.05
1.77
1.43
1.03
[1.47, 6.34]
[0.74, 4.23]
[0.46, 4.45]
[0.98, 1.08]
<0.01
0.20
0.54
0.24
336 363
Baseline respiratory disease
Chemotherapy
Nodal RT
V 25 Gy
11/205
29/839
23/561
3.07
1.74
1.25
1.04
[1.48, 6.38]
[0.73, 4.16]
[0.42, 3.72]
[0.99, 1.10]
<0.01
0.22
0.69
0.11
335 361
Baseline respiratory disease
Chemotherapy
Nodal RT
V 30 Gy
11/205
29/839
23/561
3.05
1.72
1.21
1.06
[1.47, 6.34]
[0.72, 4.10]
[0.44, 3.30]
[1.01, 1.12]
<0.01
0.23
0.71
0.04
334 360
Baseline respiratory disease
Chemotherapy
Nodal RT
V 35 Gy
11/205
29/839
23/561
3.07
1.68
1.38
1.07
[1.48, 6.38]
[0.70, 4.01]
[0.57, 3.38]
[1.01, 1.14]
<0.01
0.25
0.48
0.02
333 360
Baseline respiratory disease
Chemotherapy
Nodal RT
V 40 Gy
11/205
29/839
23/561
3.04
1.67
1.96
1.06
[1.46, 6.31]
[0.70, 4.01]
[0.89, 4.34]
[0.99, 1.13]
<0.01
0.25
0.10
0.08
335 361

n/N, number of RILI/number of patients; OR, Odds Ratio CI: Confidence Interval; RT, Radiation therapy; AIC, Akaike information criterion; BIC, Bayesian information criterion. Vx Gy: % of ipsilateral lung volume receiving x Gy. Dmean: mean dose to the ipsilateral lung (Gy); * 46 patients excluded for missing data for baseline respiratory disease (n=46) and for chemotherapy (n=2). Presented values are numerical and not EQD2. Bold values show statistically significant variables.